首页> 美国卫生研究院文献>other >Novel topoisomerase I-targeting antitumor agents synthesized from the NNN-trimethylammonium derivative of ARC-111 5H-23-dimethoxy-89-methylenedioxy-5-(2-NNN-trimethylammonium)ethyldibenzoch16-naphthyridin-6-one iodide
【2h】

Novel topoisomerase I-targeting antitumor agents synthesized from the NNN-trimethylammonium derivative of ARC-111 5H-23-dimethoxy-89-methylenedioxy-5-(2-NNN-trimethylammonium)ethyldibenzoch16-naphthyridin-6-one iodide

机译:由ARC-111的NNN-三甲基铵衍生物5H-23-二甲氧基-89-亚甲基二氧基-5-(2-NNN-三甲基铵)合成的新型拓扑异构酶I靶向抗肿瘤药)乙基二苯并ch 16-萘啶-6-碘化物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Several new TOP1-targeting agents were prepared using as an intermediate the N,N,N-trimethyl quaternary ammonium salt >2 of ARC-111. Direct displacement of the quaternary ammonium group with hydroxide, cyclopropylamine, imidazole, 1H-1,2,3-triazole, alkylethylenediamines, ethanolamine, and polyhydroxylated alkylamines provides a convenient means for furthering insight into the structure–activity relationships within this series of non-camptothecin TOP1-targeting agents. The relative TOP1-targeting activities and cytotoxicities were evaluated in RPMI8402 and P388 cells and their camptothecin-resistant variants. Their potential to serve as substrates for the efflux transporters MDR1 and BCRP, which are associated with multidrug resistance, was also assessed.
机译:以ARC-111的N,N,N-三甲基季铵盐> 2 为中间体,制备了几种新型的TOP1靶向剂。用氢氧化物,环丙胺,咪唑,1H-1,2,3-三唑,烷基乙二胺,乙醇胺和多羟基烷基胺直接取代季铵基团提供了一种方便的方法,可以进一步深入了解这一系列非-喜树碱TOP1靶向药物。在RPMI8402和P388细胞及其对喜树碱具有抗性的变体中,评估了相对于TOP1靶向活性和细胞毒性。还评估了它们作为与多药耐药性相关的外排转运蛋白MDR1和BCRP的底物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号